APG-115

APG-115 · Ascentage Pharma

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for APG-115, covering 2024-02-01 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma [Phase 2]